TrademarkDir
DEFENDER PHARMACEUTICALS
LIVE

Serial Number

88846176

Owner

Repurposed Therapeutics, Inc.

Attorney

Michael Fedrick

First Use Date

Nov 9, 2021

Filing Date

Mar 24, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DEFENDER PHARMACEUTICALS Trademark

Serial Number: 88846176 • Registration: 7269927

DEFENDER PHARMACEUTICALS is a trademark filed by Repurposed Therapeutics, Inc. on March 24, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Repurposed Therapeutics, Inc. (9 trademarks)

324 S. Hyde Park Ave, Suite 350
Tampa, FL 33606

Entity Type: 03

Trademark Details

Filing Date

March 24, 2020

Registration Date

January 9, 2024

First Use Anywhere

November 9, 2021

First Use in Commerce

November 9, 2021

Published for Opposition

October 6, 2020

Goods & Services

motion sickness treatment preparations; anti-motion sickness agents; pharmaceutical preparations for the treatment and prevention of motion sickness; nasal gel preparations for the treatment of motion sickness; nasal spray preparations

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 5, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 4, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 4, 2023 SUPC
USE AMENDMENT FILED
Nov 28, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 28, 2023 EISU
ASSIGNED TO EXAMINER
Jul 6, 2023 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 6, 2023 EXRA
SOU EXTENSION 5 GRANTED
Jun 5, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 5, 2023 AITU
SOU EXTENSION 5 FILED
May 30, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
May 30, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 17, 2022 EXRA
SOU EXTENSION 4 GRANTED
Nov 15, 2022 EX4G
SOU EXTENSION 4 FILED
Nov 15, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 15, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 2, 2022 EXRA
SOU EXTENSION 3 GRANTED
May 31, 2022 EX3G
SOU EXTENSION 3 FILED
May 31, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
May 31, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 12, 2021 EXRA
SOU EXTENSION 2 GRANTED
Nov 10, 2021 EX2G
SOU EXTENSION 2 FILED
Nov 10, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 10, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2021 EXRA
SOU EXTENSION 1 GRANTED
May 13, 2021 EX1G
SOU EXTENSION 1 FILED
May 13, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
May 13, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 1, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 6, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 6, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 16, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 1, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 17, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 16, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 16, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 16, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 15, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 31, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 29, 2020 NWOS
NEW APPLICATION ENTERED
Mar 27, 2020 NWAP

Related Trademarks

More from this Owner

MOSIQUEL

MOSIQUEL

MOSIQUEL

MOSIQUEL

MOSIQUEL

MOSIQUEL

NASASCOP

NASASCOP

NASASCOP

NASASCOP

DEFENDER PHARMACEUTICALS, INC. logo

DEFENDER PHARMACEUTICALS, INC.